Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-29

Clinical Trial Update: Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the efficacy of oral tofacitinib in combination with narrow-band UVB phototherapy for treating vitiligo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tofacitinib (tofacitinib)

Snippet

Sponsor: Lahore General Hospital | Conditions: Vitiligo | Phase 1 | Status: ACTIVE_NOT_RECRUITING